Compare Stocks: CTEV, CERT, GDRX, and TDOC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CERT Certara	$8.52 +1.2%	$7.90	$4.45 ▼ $13.88	$1.28B	1.4	2.17 million shs	1.89 million shs
CTEV Claritev	$31.54 +2.4%	$32.54	$11.50 ▼ $73.68	$522.15M	0.88	120,035 shs	184,647 shs
GDRX GoodRx	$3.39 +0.3%	$3.38	$1.77 ▼ $5.81	$1.16B	1.59	1.13 million shs	557,159 shs
TDOC Teladoc Health	$6.26 -0.6%	$7.16	$4.40 ▼ $9.89	$1.14B	2.12	3.21 million shs	2.99 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CERT Certara	+1.19%	+6.50%	+1.07%	+57.78%	-25.78%
CTEV Claritev	+1.64%	-13.38%	-14.83%	+5.56%	-39.03%
GDRX GoodRx	+0.30%	-4.78%	-1.74%	+26.97%	-17.92%
TDOC Teladoc Health	-0.89%	-3.81%	-2.34%	-18.49%	-21.06%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CERT Certara	$8.52 +1.2%	$7.90	$4.45 ▼ $13.88	$1.28B	1.4	2.17 million shs	1.89 million shs
CTEV Claritev	$31.54 +2.4%	$32.54	$11.50 ▼ $73.68	$522.15M	0.88	120,035 shs	184,647 shs
GDRX GoodRx	$3.39 +0.3%	$3.38	$1.77 ▼ $5.81	$1.16B	1.59	1.13 million shs	557,159 shs
TDOC Teladoc Health	$6.26 -0.6%	$7.16	$4.40 ▼ $9.89	$1.14B	2.12	3.21 million shs	2.99 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CERT Certara	+1.19%	+6.50%	+1.07%	+57.78%	-25.78%
CTEV Claritev	+1.64%	-13.38%	-14.83%	+5.56%	-39.03%
GDRX GoodRx	+0.30%	-4.78%	-1.74%	+26.97%	-17.92%
TDOC Teladoc Health	-0.89%	-3.81%	-2.34%	-18.49%	-21.06%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CERT Certara	2.45	Hold	$8.28	-2.84% Downside
CTEV Claritev	2.56	Moderate Buy	$44.83	42.15% Upside
GDRX GoodRx	2.08	Hold	$4.23	24.70% Upside
TDOC Teladoc Health	2.25	Hold	$7.54	20.38% Upside

Current Analyst Ratings Breakdown

Latest CTEV, CERT, GDRX, and TDOC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2026	GDRX GoodRx	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Underweight	$3.00 ➝ $4.00
8/20/2026	CTEV Claritev	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$28.00 ➝ $40.00
8/19/2026	TDOC Teladoc Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/13/2026	GDRX GoodRx	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$2.50 ➝ $3.75
8/13/2026	CTEV Claritev	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/12/2026	CTEV Claritev	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$73.00
8/12/2026	CTEV Claritev	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$22.00 ➝ $30.00
8/11/2026	GDRX GoodRx	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$4.00 ➝ $5.00
8/11/2026	GDRX GoodRx	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$4.00 ➝ $5.00
8/10/2026	CTEV Claritev	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$40.00 ➝ $45.00
8/10/2026	CTEV Claritev	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$37.00 ➝ $43.00

(Data available from 9/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CERT Certara	$418.84M	3.10	$0.77 per share	11.13	$6.67 per share	1.28
CTEV Claritev	$965.41M	0.55	$15.85 per share	1.99	($10.10) per share	-3.12
GDRX GoodRx	$796.85M	1.46	$0.40 per share	8.45	$1.81 per share	1.87
TDOC Teladoc Health	$2.53B	0.45	$1.79 per share	3.50	$7.81 per share	0.80

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CERT Certara	-$1.60M	-$0.45	N/A	30.43	N/A	-16.75%	3.86%	2.65%	11/5/2026 (Estimated)
CTEV Claritev	-$284.28M	-$17.01	N/A	N/A	N/A	-28.46%	N/A	-5.76%	N/A
GDRX GoodRx	$30.44M	$0.04	84.77	16.95	1.68	2.07%	7.22%	2.53%	11/3/2026 (Estimated)
TDOC Teladoc Health	-$200.32M	-$0.99	N/A	N/A	N/A	-7.13%	-12.15%	-5.83%	10/28/2026 (Estimated)

Latest CTEV, CERT, GDRX, and TDOC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2026	Q2 2026	CTEV Claritev	-$4.10	$1.41	+$5.51	-$3.49	N/A	$257.48 million
8/5/2026	Q2 2026	GDRX GoodRx	$0.0797	$0.08	+$0.0003	$0.02	$193.23 million	$200.41 million
8/4/2026	Q2 2026	CERT Certara	$0.0893	$0.08	-$0.0093	-$0.36	$98.09 million	$93.27 million
7/29/2026	Q2 2026	TDOC Teladoc Health	-$0.2498	-$0.21	+$0.0398	-$0.21	$615.44 million	$606.93 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CERT Certara	N/A	N/A	N/A	N/A	N/A
CTEV Claritev	N/A	N/A	N/A	N/A	N/A
GDRX GoodRx	N/A	N/A	N/A	N/A	N/A
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CERT Certara	0.30	2.55	2.55
CTEV Claritev	N/A	1.00	1.00
GDRX GoodRx	0.74	1.38	1.38
TDOC Teladoc Health	N/A	0.83	0.81

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CERT Certara	73.96%
CTEV Claritev	87.15%
GDRX GoodRx	63.77%
TDOC Teladoc Health	76.82%

Insider Ownership

Company	Insider Ownership
CERT Certara	1.08%
CTEV Claritev	7.40%
GDRX GoodRx	5.87%
TDOC Teladoc Health	0.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CERT Certara	1,576	152.54 million	150.89 million	Optionable
CTEV Claritev	3,000	16.95 million	15.69 million	Optionable
GDRX GoodRx	697	342.57 million	322.47 million	Optionable
TDOC Teladoc Health	5,600	181.68 million	180.41 million	Optionable

CTEV, CERT, GDRX, and TDOC Headlines

Recent News About These Companies

Health Catalyst (NASDAQ:HCAT) vs. Teladoc Health (NYSE:TDOC) Critical Contrast

2 hours ago | americanbankingnews.com

How to Buy Teladoc Stock (TDOC) in 2026

September 21 at 9:35 AM | fool.com

Schrodinger (NASDAQ:SDGR) and Teladoc Health (NYSE:TDOC) Head-To-Head Survey

September 21 at 4:45 AM | americanbankingnews.com

Engineers Gate Manager LP Sells 201,521 Shares of Teladoc Health, Inc. $TDOC

September 19 at 3:13 AM | marketbeat.com

Teladoc Health, Inc. (NYSE:TDOC) Receives Average Rating of "Hold" from Analysts

September 19 at 2:28 AM | americanbankingnews.com

Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of "Hold" by Analysts

September 19 at 2:28 AM | marketbeat.com

The Bull Case For Teladoc Health (TDOC) Could Change Following Weak Q2 Results And Lowered Guidance

September 18, 2026 | finance.yahoo.com

Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade

September 17, 2026 | finance.yahoo.com

Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade

September 17, 2026 | zacks.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Recursion Pharmaceuticals (RXRX), Teladoc (TDOC) and Oscar Health (OSCR)

September 16, 2026 | theglobeandmail.com

Q2 Earnings Highs And Lows: Teladoc (NYSE:TDOC) Vs The Rest Of The Online Marketplace Stocks

September 16, 2026 | finance.yahoo.com

Q2 earnings highs and lows: Teladoc (NYSE:TDOC) vs the rest of the online marketplace stocks

September 16, 2026 | msn.com

Insider Selling: Teladoc Health (NYSE:TDOC) CEO Sells 17,805 Shares

September 15, 2026 | insidertrades.com

Charles Divita III Sells 17,805 Shares of Teladoc Health (NYSE:TDOC) Stock

September 14, 2026 | marketbeat.com

VIRGINIA RETIREMENT SYSTEMS ET Al Invests $1.45 Million in Teladoc Health, Inc. $TDOC

September 13, 2026 | marketbeat.com

Teladoc Health, Inc. $TDOC Shares Purchased by WINTON GROUP Ltd

September 12, 2026 | marketbeat.com

Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life

September 12, 2026 | seekingalpha.com

Why Teladoc (TDOC) Outpaced the Stock Market Today

September 11, 2026 | finance.yahoo.com

Why Teladoc (TDOC) Outpaced the Stock Market Today

September 11, 2026 | zacks.com

ABS Direct Equity Fund LLC Takes Position in Teladoc Health, Inc. $TDOC

September 11, 2026 | marketbeat.com

Here's Why Teladoc's Integrated Care Business Deserves More Attention

September 7, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CTEV, CERT, GDRX, and TDOC Company Descriptions

Certara NASDAQ:CERT

$8.52 +0.10 (+1.19%)

Closing price 09/21/2026 04:00 PM Eastern

Extended Trading

$8.56 +0.04 (+0.53%)

As of 04:12 AM Eastern

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Claritev NYSE:CTEV

$31.54 +0.73 (+2.37%)

As of 09/21/2026 03:57 PM Eastern

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

GoodRx NASDAQ:GDRX

$3.39 +0.01 (+0.30%)

As of 09/21/2026 04:00 PM Eastern

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Teladoc Health NYSE:TDOC

$6.26 -0.04 (-0.63%)

Closing price 09/21/2026 03:58 PM Eastern

Extended Trading

$6.26 +0.00 (+0.08%)

As of 04:03 AM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CTEV, CERT, GDRX, and TDOC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CTEV, CERT, GDRX, and TDOC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CTEV, CERT, GDRX, and TDOC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CTEV, CERT, GDRX, and TDOC Company Descriptions

Certara NASDAQ:CERT

Claritev NYSE:CTEV

GoodRx NASDAQ:GDRX

Teladoc Health NYSE:TDOC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CTEV, CERT, GDRX, and TDOC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CTEV, CERT, GDRX, and TDOC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CTEV, CERT, GDRX, and TDOC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CTEV, CERT, GDRX, and TDOC Company Descriptions

Certara NASDAQ:CERT

Claritev NYSE:CTEV

GoodRx NASDAQ:GDRX

Teladoc Health NYSE:TDOC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools